Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4159158
Max Phase: Preclinical
Molecular Formula: C51H61N7O6
Molecular Weight: 868.09
Molecule Type: Small molecule
Associated Items:
ID: ALA4159158
Max Phase: Preclinical
Molecular Formula: C51H61N7O6
Molecular Weight: 868.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCn1cc(C[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC)C(=O)N[C@@H](CC(C)C)C(=O)O)c2ccccc21
Standard InChI: InChI=1S/C51H61N7O6/c1-5-6-25-58-32-37(39-22-14-16-24-46(39)58)30-44(50(62)57-45(51(63)64)26-33(2)3)56-48(60)42(28-35-19-11-8-12-20-35)54-49(61)43(29-36-31-53-40-23-15-13-21-38(36)40)55-47(59)41(52-4)27-34-17-9-7-10-18-34/h7-24,31-33,41-45,52-53H,5-6,25-30H2,1-4H3,(H,54,61)(H,55,59)(H,56,60)(H,57,62)(H,63,64)/t41-,42+,43-,44-,45+/m1/s1
Standard InChI Key: OLCXGQPDICIEHO-VSOUDBLZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 868.09 | Molecular Weight (Monoisotopic): 867.4683 | AlogP: 5.85 | #Rotatable Bonds: 23 |
Polar Surface Area: 186.45 | Molecular Species: ACID | HBA: 7 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 3.89 | CX Basic pKa: 8.34 | CX LogP: 4.86 | CX LogD: 4.82 |
Aromatic Rings: 6 | Heavy Atoms: 64 | QED Weighted: 0.04 | Np Likeness Score: -0.13 |
1. Haitham Abusara O, Freeman S, Aojula HS.. (2017) Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain., 137 [PMID:28595067] [10.1016/j.ejmech.2017.05.053] |
Source(1):